Economic Outcomes of Hexaminolevulinate Blue-Light Cystoscopy in Non-Muscle Invasive Bladder Cancer: A 5-Year, Medicare-Based Model [0.03%]
基于 Medicare 的 5 年模型评估光敏膀胱镜检查在非肌层浸润性膀胱癌中的经济学效果
Michael L Creswell,Tamir N Sholklapper,Michael J Markel et al.
Michael L Creswell et al.
Background: Bladder cancer is the most expensive cancer to treat on a per-patient basis. Blue light cystoscopy with hexaminolevulinate (BLC) has demonstrated improved diagnostic accuracy compared with white light cystosco...
Mark S Soloway,Neil A Abrahams
Mark S Soloway
The Role of Local Agents for the Treatment of Localized Upper Tract Urothelial Carcinoma: A Review of the Current Evidence [0.03%]
局部上尿路尿路上皮癌治疗中局部分子标志物的作用：现有证据综述
Anastasios D Asimakopoulos,Maxim Kochergin,Christian Klöcker et al.
Anastasios D Asimakopoulos et al.
Kidney-sparing surgery (KSS) for upper urinary tract urothelial carcinoma (UTUC) is a promising alternative to radical nephroureterectomy, especially for low-risk cases. However, due to the established risk of ipsilateral UTUC recurrence ca...
An Association Study of Germline Variants in Bladder Cancer-Related Genes with the Prognosis of Non-Muscle Invasive Bladder Cancer [0.03%]
膀胱癌相关基因 germline变异与非肌层浸润性膀胱癌预后关系的队列研究
Jasper P Hof,Sita H Vermeulen,Antoine G van der Heijden et al.
Jasper P Hof et al.
Background: Various germline genetic variants are associated with the prognosis of non-muscle invasive bladder cancer (NMIBC). Germline variants in genes frequently somatically mutated in bladder cancer have not been stud...
Recent Advances in the Classification of Bladder Cancer - Updates from the 5th Edition of the World Health Organization Classification of the Urinary and Male Genital Tumors [0.03%]
WHO泌尿和男性生殖道肿瘤分类（第5版）中的膀胱癌分型进展
Charles C Guo,Steven S Shen,Bogdan Czerniak
Charles C Guo
Background: The World Health Organization Classification (WHO) of Urinary and Male Genital Tumors has recently been updated to its 5th edition. The new edition presents a comprehensive approach to the classification of ur...
Is There A Benefit of Restaging Transurethral Resection of Bladder Tumor Prior to Radical Cystectomy With or Without Neoadjuvant Chemotherapy? [0.03%]
经尿道膀胱肿瘤切除术复发病变的根治性膀胱切除术的价值：伴有或不伴新辅助化疗
Justin P Mehr,Jenna N Bates,Seth P Lerner
Justin P Mehr
Background: One of the best predictors of positive outcomes in bladder cancer (BC) is pT0 following radical cystectomy (RC). Discordance between clinical and pathologic staging affects decision-making in patients with cli...
The Association between Diabetes Medication Use and Tumour Characteristics at Diagnosis in Patients with Urothelial Carcinoma: A Retrospective Registry-Based Study [0.03%]
糖尿病药物使用与尿路上皮癌患者诊断时肿瘤特征之间的关联：一项基于回顾性登记表的研究
Janine P M Faessen,Dennis J A J Oerlemans,Marc R P A de Jong et al.
Janine P M Faessen et al.
Background: Observational studies indicate a potential association between diabetes medication use and aggressiveness of bladder cancer. Objective: ...
Piyush K Agarwal,Cora N Sternberg
Piyush K Agarwal
SH3BP5-AS1/IGF2BP2/VDAC2 Axis Promotes the Apoptosis and Ferroptosis of Bladder Cancer Cells [0.03%]
SH3BP5-AS1/IGF2BP2/VDAC2轴促进膀胱癌细胞的凋亡和铁死亡
Yong Shao,Yunhui Chan,Rong Zhao
Yong Shao
Background: Bladder cancer (BC) is the most common malignant tumor in the urinary system with a high incidence, imposing a burden on the healthcare system worldwide. The participation of long non-coding RNAs (lncRNAs) in ...
Editorial Concerning "The Association Between Diabetes Medication Use and Tumour Characteristics at Diagnosis in Patients with Urothelial Carcinoma: A Retrospective Registry-Based Study" [0.03%]
关于“糖尿病用药与尿路上皮癌患者诊断时肿瘤特征关联的回顾性登记队列研究”的编辑部论文
Lambertus A L M Kiemeney
Lambertus A L M Kiemeney